In-Vitro Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2018-2025

1
Global In-Vitro Diagnostics Market

• Drivers, Restraints, Potential Growth
  Opportunities, Product Size, Application
  Estimation, Vendor Competitive Landscape, Trends
  and Forecast 2018-2025

Single Use License US 4200
Request Sample
2
Global In-Vitro Diagnostics Market

• The global IVD market size accounted for xx
  billion in 2016. It is projected to reach xx
  billion with a CAGR of xx over the forecast
  period. IVD are medical devices, used to identify
  the condition of the disease. Biological samples
  such as urine, blood, tissues, body fluids and
  stool are required to detect conditions,
  infections, and diseases. These tests give
  accurate results and are easily performed. IVD
  products can be reagents, instruments or method
  used for the diagnosis of disorders.The high rate
  in the occurrence of infectious and chronic
  disorder and a large number of geriatric
  residents drive the IVD market globally.
  Additionally, the increase in a number of private
  and public diagnostic centers is anticipated to
  boost the market during the forecast period. In
  addition, growth in investment for the
  development of the healthcare segment by the
  government is expected to fuel the growth of the
  global IVD market. Though, strict rules of
  government for the production of IVD products and
  compensation plans are projected to affect the
  growth of the IVD industry.
• Increase in the occurrence of chronic diseases
  Currently, there is an occurrence in chronic
  diseases such as cancer, tuberculosis (TB),
  diabetes and cardiovascular diseases. Moreover,
  there is also a significant increase in patients
  suffering from infectious diseases such as
  sexually transmitted diseases, respiratory and
  gastrointestinal diseases. The demand for IVD is
  increasing due to a rise in infectious and
  chronic disorders propelling the IVD market size.
• Browse the complete report on _at_
  https//www.adroitmarketresearch.com/industry-repo
  rts/in-vitro-diagnostics-market

3
Global In-Vitro Diagnostics Market

• Increase in the occurrence of chronic diseases
  Currently, there is an occurrence in chronic
  diseases such as cancer, tuberculosis (TB),
  diabetes and cardiovascular diseases. Moreover,
  there is also a significant increase in patients
  suffering from infectious diseases such as
  sexually transmitted diseases, respiratory and
  gastrointestinal diseases. The demand for IVD is
  increasing due to a rise in infectious and
  chronic disorders propelling the IVD market size.
• Technological Developments Previously, IVD
  technologies were performed in clinical labs.
  Traditionally, pregnancy tests were performed in
  laboratories, but, nowadays, they can be
  performed at home by placing the urine sample on
  the test stick. These tests are easy to perform,
  less time-consuming and accurate. In the same
  manner, testing of blood glucose level can also
  be done, using point of care devices such as a
  glucometer.
• Due to development in IVD technologies, there is
  an upsurge in the IVD industry. Currently, in
  Europe Life Technology corporation introduced
  CE-IVD Marked QuantStudio Dx Real-Time PCR
  instrument. This PCR offers diagnostic functions
  such as SNP genotyping, micro-RNA, pathogen
  detection, and mutation detection copy number
  analysis and gene expression analysis.
• Technique Insights Technique section is divided
  into blood testing, immunodiagnostics, molecular
  diagnostics, clinical chemistry and tissue
  diagnostics. Immunodiagnostics consists of
  enzyme-linked immunospot, radioimmunoassay,
  western blot, rapid tests, and enzyme-linked
  immunosorbent assay. Molecular diagnostics
  include DNA diagnostics, polymerize chain
  reaction, microarray, isothermal nucleic acid
  technology, hybridization and many more. Clinical
  chemistry is divided into lipid profile,
  electrolyte panel, basic metabolic panel, thyroid
  function panel, and liver profile. Clinical
  chemistry holds the largest share in the IVD
  market.

4
Global In-Vitro Diagnostics Market

• Product Overview In 2016, reagents held the
  largest market share because of its use in large
  amount. Reagents such as specific antibodies,
  protein biomarker, fluorescent tags, and washing
  buffer are used in immunochemistry assay.
• Various chemicals such as magnesium chloride or
  salts, dNTP, primer are used for performing PCR.
  Most frequently used reagents for molecular
  diagnostic techniques are fluorescent-labeled
  nucleotides and primers. Reagents are playing a
  major role in the RD department which is helping
  to increase the demand of the IVD market.
• Application Overview The market is segmented
  into diabetes, drug testing, nephrology,
  cardiology, autoimmune diseases, infectious
  diseases, cancer or oncology.
• End-User Overview IVD is used in laboratories,
  by patients for self-testing, academic
  institutes, and hospitals.
• Benefits of In-Vitro Diagnostics
• Multiple Tests at the Same Time Allows various
  markers to be detected at the same time and also
  helps in testing of drugs at different
  concentrations.
• Easily Records the Data Easy for the clinician
  to record or process the information in form of
  scanned image or photocopy.

5
Global In-Vitro Diagnostics Market

• Customizable to detect various chemicals IVD are
  used in detecting specific markers. Clinicians
  have a large collection of chemicals that can be
  detected. Chemicals can be in the form of
  biological molecules, such as heroin a synthetic
  narcotic or hemoglobin in red blood cells.
• Quick Results IVD tests can produce results in
  minutes exposing the sample.
• Regional Overview North America holds the
  largest IVD market share. The occurrence of
  infectious disorders such as cancer and
  respiratory disorders are the factors involved in
  increasing IVD market size. In 2016, Europe was a
  second largest market and is projected to witness
  a substantial growth in the coming years. The
  Asia Pacific is the fastest growing region over
  the forecast period.
• Key Players Players involved in the development
  of IVD market share are Abbott Laboratories,
  Thermo Fischer Scientific, Sysmex Corporation,
  Roche Diagnostics, Dickinson and Company,
  Ortho-Clinical Diagnostics and many more.
• Purchase a single user copy of the global
  In-Vitro Diagnostics market report _at_
  https//www.adroitmarketresearch.com/researchrepor
  t/purchase/88

6
About Us

• Adroit Market Research is an India-based business
  analytics and consulting company. Our target
  audience is a wide range of corporations,
  manufacturing companies, product/technology
  development institutions and industry
  associations that require understanding of a
  markets size, key trends, participants and
  future outlook of an industry. We intend to
  become our clients knowledge partner and provide
  them with valuable market insights to help create
  opportunities that increase their revenues. We
  follow a code Explore, Learn and Transform. At
  our core, we are curious people who love to
  identify and understand industry patterns, create
  an insightful study around our findings and churn
  out money-making roadmaps. Our analysts have
  tracked high growth markets in chemicals
  materials, healthcare pharmaceuticals,
  semiconductor electronics, energy power, food
  retail, consumer goods, technology, and
  machinery equipment sectors across the world to
  identify new opportunities, potential customers,
  prepare go-to-market (GTM) strategies, identify
  segments for revenue growth for companies, and
  many more.

• US Headquarters3131 McKinney Ave Ste 600
  Dallas, TX 75204 ,U.S.A 

• Phone [phone]
• Email sales_at_adroitmarketresearch.com